ArticleJournal of clinical laboratory analysis2021

Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.

Jiang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.